David against Goliath: may we target and defeat interstitial lung disease in systemic sclerosis?
- PMID: 17543137
David against Goliath: may we target and defeat interstitial lung disease in systemic sclerosis?
Comment on
-
A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.Clin Exp Rheumatol. 2007 Mar-Apr;25(2):287-92. Clin Exp Rheumatol. 2007. PMID: 17543155 Clinical Trial.
-
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase.Clin Exp Rheumatol. 2007 Mar-Apr;25(2):293-6. Clin Exp Rheumatol. 2007. PMID: 17543156 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical